Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trial
Li Zang(First Affiliated Hospital of Xinxiang Medical University), Yimin Mu(Chinese PLA General Hospital), Jing Liu(Qingdao University), Yixin Sun, Heidrun Bosch‐Traberg(University of Copenhagen), Jin Geng(Harrison International Peace Hospital), Xiaoyi Lv(Xinjiang University), Fang Bian(Hospital of the University of Pennsylvania), Ying‐Ying Liu(Second Affiliated Hospital of Jilin University), Yan Peng(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Yuan Luo(Chongqing Three Gorges Central Hospital), Jian Yang(Minhang District Central Hospital), Yanrong Li(Shanghai Veterinary Research Institute)
Cited by 42
Related Papers
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
|New England Journal of Medicine|2024|1.5k
Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis
|Computers in Biology and Medicine|2022|183
Serum Raman spectroscopy combined with convolutional neural network for rapid diagnosis of HER2-positive and triple-negative breast cancer
|Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy|2022|156